"As Low As $X/Month": The Fine Print Behind Every Headline Price
"As low as $99/month" is technically true and functionally misleading at a lot of providers — that price usually applies to exactly one scenario, and it's rarely the one you'll actually experience. Here's the fine print behind the headline number.
What "as low as" usually actually means
- The lowest possible dose, typically your very first month only
- Sometimes a promotional or first-time-customer rate that reverts to a higher price after
- Occasionally the price before mandatory add-ons (consultation, labs) are included
What it usually doesn't mean
Your actual ongoing cost once you've titrated to a typical maintenance dose, which for many GLP-1 protocols is considerably higher than the induction dose — sometimes double or more, depending on the provider's dose-based pricing structure.
Wellorithm From $147
Compounded semaglutide and tirzepatide — ask specifically what dose the advertised starting price applies to, and what maintenance dose typically costs.
SHED From $199
A physician-led program — confirm pricing at your likely maintenance dose, not just the advertised starting figure.
The one question that cuts through this
Ask directly: "What will I pay per month once I'm on a typical maintenance dose, not the starting dose?" That number — not the homepage headline — is the one to actually compare across providers.